PRE-084

A sigma-1 receptor agonist derived structurally from PCP. It has cognitive enhancing effects as well as antidepressant effects, and shows promise in treating many nervous system diseases such as ALS and parkinsons.

Also known as: Uurimisliga PRE-084

Classification

Psychoactive: Depressant
Tag: Tentative

Effects

Stimulation
Insomnia
Sedation
Motor Impairment
Increased Focus
Euphoria
Reduced Anxiety
Dulled Perception

Routes of Administration

Oral

Dosage

Heavy: 60+ mg
Light: 2–10 mg
Common: 10–30 mg
Strong: 30–60 mg
Threshold: 1–2 mg

Duration

Onset: 0.25-0.75 h
Peak: 1-2 h
Offset: 2-3 h
After Effects: 3-5 h
Total Duration: 3-5 h

Sublingual

Dosage

Heavy: 60+ mg
Light: 2–10 mg
Common: 10–30 mg
Strong: 30–60 mg
Threshold: 1–2 mg

Duration

Onset: 0.25-0.5 h
Peak: 1-2 h
Offset: 2-3 h
After Effects: 3-5 h
Total Duration: 3-5 h

Insufflated

Dosage

Heavy: 40+ mg
Light: 2–8 mg
Common: 8–20 mg
Strong: 20–40 mg
Threshold: 1–2 mg

Duration

Onset: 0.08-0.25 h
Peak: 0.75-1.5 h
Offset: 1.5-2.5 h
After Effects: 2.5-4 h
Total Duration: 3-4 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

tripsit.me

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

PRE-084

Classification

Effects

Routes of Administration

Oral

Sublingual

Insufflated

Harm Reduction

Sources

Links

Get the full DrugsPRO experience

PRE-084 - DrugsPRO ainejuhend